Opinion
№9 1 2007

THE HER2/NEU EXPRESSION IN NON-SMALL CELL LUNG CANCER: PROGNOSTIC VALUE

Qian Z.

The paper summarizes literature and own findings dealing with the role of Her2/neu in the molecular biological pattern of non-small cell lung cancer (NSCLC). It is concluded that its overexpression may serve as a chemoresistance marker and negative prognostic factor for NSCLC.

Keywords:
, , ,
Full article in PDF format
Views: 2

Статьи по теме:

  1. HER2E AS A TARGET FOR THERAPY IN NO-SMALL CELL LUNG CANCER
  2. PROGNOSTIC FACTORS AND EXAMINATION SCHEDULES IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
  3. MODERN TREATMENT MODALITIES IN NON-OPERABLE NON-SMALL CELL LANG CANCER
  4. EFFICACY OF ZOLEDRONATE IN METASTATIC BONE DISEASE MANAGEMENT FOR PATIENTS WITH DIFFERENT PRIMARY TUMORS
No comments » Add comment

Publisher MORION Apteka online Компендиум — справочник лекарств №1 Chasopys online Oncology